Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn

OCT scanner

Sep 2009
Michelson Diagnostics Ltd.Request Info
Michelson Diagnostics Ltd. has introduced the VivoSight, a multibeam OCT scanner with applications in the diagnosis, monitoring and treatment of various forms of cancer. The device uses a handheld probe to provide images of skin and other surface tissue with an isotropic resolution of >10 μm up to a depth of 2 mm. Its scan width can be varied up to 5 mm, and it scans at rates ranging from 6.5 to 35 fps. In the US, the scanner is available for nonclinical applications only.


* Message:
(requirements, questions for supplier)
Your contact information
* First Name:
* Last Name:
* Email Address:
* Company:
Address 2:
Postal Code:
* Country:
Phone #:
Fax #:

Register or login to auto-populate this form:
Login Register
* Required

When you click "Send Request", we will record and send your personal contact information to Michelson Diagnostics Ltd. by email so they may respond directly. You also agree that Photonics Media may contact you with information related to this inquiry, and that you have read and accept our Privacy Policy and Terms and Conditions of Use.
BiophotonicsBreakthroughProductscancerDiagnosishand-held probeimagingisotropic resolutionMichelson Diagnostics LtdmonitoringMultiBeamnon-clinicalOCTOCT scannerscan ratesscan widthtreatmentVivoSight

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
Are you interested in this product?
When you click "Send Request", we will send the contact details you supply to Michelson Diagnostics Ltd. so they may respond to your inquiry directly.

Email Address:
Stop showing me this for the remainder of my visit
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.